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scriptional upregulation in all cases up to two magnitudes
was observed (Fig 2a). For one of the probands, the ex-
pression was also assayed by Western blot analysis, which
confirmed the upregulation of hCAP18 on the protein level
with evidence of the cleaved peptide LL-37 (Fig 2b). Topical
treatment with 1,25(OH)2D3 also produced upregulation of
hCAP18 in skin in vivo (not shown).
Our results confirm the findings of Wang et al (2004) and
in addition delineate the effects exerted by different vitamin
D compounds. Most importantly, we here demonstrate the
upregulation of hCAP18 in human skin in vivo following a
single application of vitamin D compounds topically. These
findings reveal an intriguing mechanism to enhance skin
protection, linking the UVB-dependent photochemical vita-
min D with hCAP18, involved in wound repair and antimi-
crobial defense. Under normal conditions, skin is the major
source of vitamin D in humans and its production is
dependent on ultraviolet radiation. UVB acts on the precur-
sor 7-DHC and forms provitamin D3, which is thermally
transformed to vitamin D3. Further hydroxylation steps to
produce 1,25(OH)2D3 occur in the liver and kidney, but also
skin keratinocytes contain the enzymatic machinery to fully
hydroxylate vitamin D3 and produce their own 1,25(OH)2D3
(Bikle et al, 1986). If exposure to sunlight is limited, the body
depends upon dietary intake of vitamin D3 from animal
food and vitamin D2 from plants. Since all vitamin D met-
abolites including vitamin D2 displayed significant activity,
this suggests that vitamin D regulation of hCAP18 may be a
conserved mechanism and not restricted to the skin.
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Reporting Hardy–Weinberg Tests in Case–Control Studies:
Reasons for Caution but not for Panic Reactions
To the Editor:
In this journal, Gyo¨rffy et al (2004) recently criticized the
failure to report results from statistical tests of Hardy–Wein-
berg equilibrium (HWE) in some case–control studies, also
citing our paper (Richter-Hintz et al, 2003). The authors
claimed that information about results from testing HWE
should be obligatory because deviations of the genotype
Figure 2
The expression of CAMP is upregulated by calcipotriol in human
skin in vivo. (a) Real-Time RT-PCR expression analysis was performed
on cDNA from skin biopsies of four probands locally treated with ca-
lcipotriol as described above. The stimulation of CAMP expression af-
ter treatment is shown relative to the respective untreated sample,
which is set as 1 (not shown). The biopsy also analyzed by Western blot
analysis is marked with an asterisk. (b) Western blot analysis on protein
extracts of skin biopsies obtained as described above.
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distribution in case and control groups, respectively, from
HWE can have considerable consequences for conclusions
made in all studies. Alarmed through the raised objection
that we might have misinterpreted our data, we carefully
considered Gyo¨rffy et al’s arguments.
In our study, we focused on the genetic variability of
seven loci that are considered to be related to a risk for
psoriasis (Richter-Hintz et al, 2003). In the case of two loci,
GSTM and NQOR, Gyo¨rffy et al found deviations from
HWE and stated that our conclusions are not tenable. But
tests for HWE are not available that can be applied to
dominant-recessive markers with only two alleles, e.g.,
GST. The genotype distribution of the NQOR locus indeed
deviated significantly from HWE, but the risk of mistyping
genotypes can increase the probability of making type II
errors (i.e., erroneously accepting deviations from HWE).
Assuming that only two rare NQOR homozygotes are not
classified correctly and using the Bonferroni correction for
multiple testing, no significant deviation from HWE was
found (p¼0.028). Therefore, we conclude that Gyo¨rffy
et al’s criticism based on their meta-analysis has no solid
basis for all of the reported cases.
Nevertheless, we agree with Gyo¨rffy et al’s statement
that genotypic data of case–control studies must first be
tested for deviations from HWE and results should be re-
ported. Deviations from HWE can point to either a sampling
bias, mistyping of genotypes, or spurious gene associations
because of population stratification. If genotype frequencies
of both groups do not deviate significantly from HWE, there
are no serious concerns about the genetic structure of
samples. If only the genotype distribution of the patient
group shows deviation from HWE, this may provide addi-
tional support for an association of the marker locus with
the disease in question. If, however, the genotype frequen-
cies found in the control group deviate from HWE, data
must be reanalyzed carefully for all the reasons mentioned
above.
Finally, although it would be best to analyze first the
control group genetic testing in clinical research has to fit
into practical possibilities. Nevertheless, we want to stress
that a case–control design can be an optimal choice for
many human genetic studies when appropriate statistics
and population genetic concepts are applied (Schulze and
McMahon, 2002).
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A Novel Deletion Mutation in Keratin 5 Causing the Removal
of 5 Amino Acids and Elevated Mutant mRNA Levels in
Dowling–Meara Epidermolysis Bullosa Simplex
To the Editor:
Epidermolysis bullosa simplex (EBS) is one of the three
broad groups into which cases of Epidermolysis bullosa are
classified on the basis of clinical, histological, and genetic
evidence obtained from the affected patient (Pulkkinen et al,
1999). EBS is further classified into three subgroups, EBS
Weber–Cockayne (EBS-WC), EBS Koebner (EBS-K), and
EBS Dowling–Meara (EBS-DM), on the basis of the severity
and distribution of the symptoms, the age of onset, and the
ultrastructural investigation of the epidermis and basement
membrane zone.
The phenotypic manifestations of the different subtypes
of EBS have been extensively reviewed elsewhere, as has
the experimental evidence initially linking keratins 5 (KRT5)
and 14 (KRT14) mutations to EBS (Fine et al, 1991; Ishida-
Yamamato, 1991; Vassar, 1991; Fine et al, 2000). The char-
acteristic bullae or blisters seen in EBS result from the lysis
of unusually fragile basal keratinocytes as a result of mu-
tations in the genes encoding KRT5 and KRT14. EBS-DM is
considered the most severe form of EBS with widespread
herpetiform blistering, frequent extracutaneous involve-
ment, and evidence of tonofilament clumping at the elec-
tron microscope level in basal keratinocytes (Irvine et al,
1999; Fine et al, 2000).
Here we report the identification of a novel mutation in
the 2B helical region of KRT5 in a three-generation non-
consanguinous Australian family of caucasian extraction
(Fig 1). The proband was the only member of the family to
Abbreviations: EBS, epidermolysis bullosa simplex; GAPDH,
glycerylaldehyde-3-phosphate; KRT5, keratin 5; KRT14, keratin
14; qPCR, quantitative polymerase chain reaction
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